Shandong Awa Biopharm

Shandong Awa Biopharm is a vertically integrated biotechnology company headquartered in Binzhou, China, specializing in the microbial fermentation and production of Sodium Hyaluronate (Hyaluronic Acid). The company controls the entire production cycle from raw material API synthesis to the formulation of finished medical devices, including cross-linked dermal fillers and ophthalmic viscoelastics. Awa Biopharm utilizes advanced purification and cross-linking technologies to supply high-quality HA to the pharmaceutical, aesthetic, and nutraceutical industries. Their manufacturing facilities are compliant with international standards, supporting a global distribution network across more than 40 countries. Key applications of their portfolio include the treatment of osteoarthritis, ophthalmic surgical support, and cosmetic dermatology.